Helius Medical Technologies - Home

SIGNUP FOR NEWSLETTER

TSX: HSM     NASDAQ: HSDT

Call us: +1 877-564-0008

Menu

Stock Quote - HSDT

*Delayed quote courtesy of Google.

2019 News

Filters
List of articles in category 2019 News
Title Date
Independent Research Published Show Positive Results on Translingual Neurostimulation Plus Physical Therapy With Statistically Significant Improvement in Balance and Gait Scores and the Outcomes Were Sustained for 12 Weeks After Discontinuing Treatment 19 Dec, 2019
Helius Medical Technologies, Inc. Announces Pricing of Public Offering 22 Nov, 2019
Helius Medical Technologies, Inc. Announces Proposed Public Offering 21 Nov, 2019
Helius Medical Technologies, Inc. Announces Addition of P3 Health As New Authorized PoNS Treatment™ Clinic in Toronto, Canada 19 Nov, 2019
Helius Medical Technologies, Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update; Updates Full Year 2019 Outlook 12 Nov, 2019
Helius Medical Technologies, Inc. Announces Update on US Regulatory Strategy Following Pre-Submission Meeting with FDA 24 Oct, 2019
Helius Medical Technologies to Release Third Quarter of Fiscal Year 2019 Financial Results on November 12, 2019 01 Oct, 2019
Helius Medical Technologies, Inc. Announces Addition of a New PoNS™ Clinic in Quebec City, Canada 13 Sep, 2019
Helius Medical Technologies, Inc. Provides a Business Update on Clinical Experience to Date in Canada 28 Aug, 2019
Helius Medical Technologies, Inc. Reports Second Quarter 2019 Financial Results and Provides Business Update; Reaffirms Full Year 2019 Outlook 08 Aug, 2019
Helius Medical Technologies, Inc. Announces Results of Matters Submitted for Vote at 2019 Annual Meeting of Stockholders 12 Jul, 2019
Helius Medical Technologies to Release Second Quarter of Fiscal Year 2019 Financial Results on August 8, 2019 02 Jul, 2019
Helius Medical Technologies, Inc. Provides a Business Update on FDA Strategy 18 Jun, 2019
Helius Medical Technologies, Inc. Announces Scientific Publication Confirming Tongue Stimulation with PoNS™ Alters Brain Activity 11 Jun, 2019
Helius Medical Technologies to Present at the JMP Securities Life Sciences Conference 07 Jun, 2019
Helius Medical Technologies, Inc. Announces Addition of Three New PoNS™ Authorized Clinics in Canada 05 Jun, 2019
Helius Medical Technologies, Inc. Reports First Quarter 2019 Financial Results and Provides Business Update; Reaffirms Full Year 2019 Outlook 09 May, 2019
Helius Medical Technologies, Inc. Provides Update on FDA’s Review of its Request for De Novo Classification and 510(k) Clearance of the PoNS™ Device 10 Apr, 2019
Helius Medical Technologies to Release First Quarter of Fiscal Year 2019 Financial Results on May 9, 2019 02 Apr, 2019
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results and Introduces Full Year 2019 Outlook 14 Mar, 2019
Helius Medical Technologies, Inc. to Present at Oppenheimer’s 29th Annual Healthcare Conference 06 Mar, 2019
Helius Medical Technologies, Inc. Announces First Patients in Canada Treated with Commercially Available PoNS™ Treatment 05 Mar, 2019
Helius Medical Technologies, Inc. Announces Company-Hosted Event at Medical Meeting in March 28 Feb, 2019
Uptick Newswire Hosts Helius Medical Technologies, Inc. on the Stock Day Podcast to Discuss the Company’s Clearance in Canada and Expansion into The United States and Europe 11 Feb, 2019
Helius Medical Technologies to Release Fourth Quarter and Fiscal Year 2018 Financial Results on March 14, 2019 07 Feb, 2019
Helius Medical Technologies, Inc. Provides Update on FDA’s Review of its Request for De Novo Classification and 510(k) Clearance of the PoNS™ Device 25 Jan, 2019
Helius Medical Technologies, Inc. Announces Fourth Partnership to Implement Clinical Experience Programs with PoNS™ Treatment in the United States 03 Jan, 2019
Helius Medical Technologies, Inc. Announces Third Collaboration to Implement Clinical Experience Programs with PoNS™ Treatment in the United States 03 Jan, 2019